Investigation of copeptin levels in foetal congenital central nervous system anomalies

References

• Bahado-Singh RO, Khalek N, Short A. 2007. Ultrasound technology for the accurate detection of fetal anomalies. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 1:34–38.
   Google Scholar
• Balakumar K. 2004. Antenatal ultrasound screening for anomalies among singletons – results of a prospective study. Calicut Medical Journal 2:e9.
   Google Scholar
• Becker R, Mende B, Stiemer B, Entezami M. 2000. Sonographic markers of exencephaly at 9 + 3 weeks of gestation. Ultrasound in Obstetrics & Gynecology : The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 16:582–584.
   PubMed Web of Science ®Google Scholar
• Ben Sira L, Garel C, Leitner Y, Gross-Tsur V. 2008. Prenatal imaging of the fetal brain-indications and developmental implications of fetal MRI. Harefuah 147:65–70.
   PubMedGoogle Scholar
• Boer GJ, Van Rheenen-Verberg CMH, Uylings H. 1982. Impaired brain development of the diabetes insipidus Brattleboro rat. Developmental Brain Research 3:557–575.
   Google Scholar
• Carroll SG, Porter H, Abdel-Fattah S, Kyle PM, Soothill PW. 2000. Correlation of prenatal ultrasound diagnosis and pathologic findings in fetal brain abnormalities. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 16:149–153.
   PubMed Web of Science ®Google Scholar
• Cetin O, Karaman E, Boza B, Cim N, Alisik M, Erel O, et al. 2017. Relationship between maternal blood ceruloplasmin level, catalase and myeloperoxidase activity and neural tube defects. Ginekologia Polska 88:156–160.
   PubMed Web of Science ®Google Scholar
• Dane B, Dane C, Sivri D, Kiray M, Çetin A, Yayla M. 2007. Ultrasound screening for fetal major abnormalities at 11-14 weeks. Acta Obstetricia et Gynecologica Scandinavica 86:666–670.
   PubMed Web of Science ®Google Scholar
• Dobsa L, Edozien KC. 2013. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochemia Medica 23:172–190.
   Web of Science ®Google Scholar
• Engels A C, Joyeux L, Brantner C, De Keersmaecker B, De Catte L, Baud D, et al. 2016. Sonographic detection of central nervous system defects in the first trimester of pregnancy. Prenatal Diagnosis 36: 266–273.
   PubMed Web of Science ®Google Scholar
• Ghavami M, Abedinzadeh R. 2011. Prevalence of perinatal central nervous system anomalies in East Azarbaijan-Iran. Iranian Journal of Radiology: a Quarterly Journal Published by the Iranian Radiological Society 8:79–81.
   PubMed Web of Science ®Google Scholar
• Grande M, Arigita M, Borobio V, Jimenez JM, Fernandez S, Borrell A. 2012. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 39:157–163.
   PubMed Web of Science ®Google Scholar
• International Society of Ultrasound in Obstetrics and Gynecology Education Committee. 2007. Sonographic examination of the fetal central nervous system: guidelines for performing the 'basic examination' and the 'fetal neurosonogram'. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 29:109–116.
   PubMed Web of Science ®Google Scholar
• Joosen AM, van der Linden IJ, Schrauwen L, Theeuwes A, de Groot MJ, Ermens AA. 2017. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy. Clinical Chemistry and Laboratory Medicine (CCLM) 56:113–119.
   Google Scholar
• Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, et al. 2009. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Annals of Neurology 66:799–808.
   PubMed Web of Science ®Google Scholar
• Kınay T, Kaplan M, Altay MM, Özdemirci Ş, Karadeniz S, Erol AO. 2016. Results of fetal anomaly screening performed at 11- 14 weeks of gestation at a tertiary center. Perinatal Journal 24:100–105.
   Google Scholar
• Kose S, Altunyurt S, Keskinoglu PA. 2018. prospective study on fetal posterior cranial fossa assessment for early detection of open spina bifida at 11–13 weeks. Congenital Anomalies 58:4–9.
   PubMed Web of Science ®Google Scholar
• Lewandowski K, Brabant G. 2016. Potential clinical utility of copeptin (c-terminal provasopressin) measurements in clinical medicine. Experimental and Clinical Endocrinology and Diabetes 124:173.
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Alonso C, Bergmann A. 2006. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry 52:112–119.
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Jochberger S, Dünser MW. 2008. Copeptin: clinical use of a new biomarker. Trends in Endocrinology and Metabolism 19:43–49.
   PubMed Web of Science ®Google Scholar
• Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, et al. 2015. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. European Heart Journal 36:369–376.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. 2011. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagnosis 31:90–102.
   PubMed Web of Science ®Google Scholar
• Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. 2006. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Research. Part A, Clinical and Molecular Teratology 76:230–236.
   PubMedGoogle Scholar